最高法院法官塞缪尔·阿利托暂时延长了一项命令，该命令保持全国范围内通过邮件和远程医疗访问获得避孕药米非司酮。
将于周一到期的行政暂缓令将持续到美国东部时间周四下午5点。阿利托没有详细说明这一决定。
最高法院正在考虑生产米非司酮的制药公司提出的紧急申请，以解除下级法院的一项裁决，该裁决禁止远程医疗服务提供商在诉讼继续进行期间分发或通过邮件分发该药物。
路易斯安那州禁止在怀孕的所有阶段堕胎，只有有限的例外，该州最初提起诉讼是为了阻止邮购堕胎药丸，声称联邦监管机构在停止亲自看医生的要求时没有适当考虑安全风险。
制药商、公共卫生组织和堕胎权利倡导者坚持认为，已经进行了法律授权的审查，该药物的不良反应率低于青霉素和伟哥。
在最高法院于2022年推翻罗诉韦德案后，米非司酮成为诉讼的目标。2024年，大法官们一致否决对米非司酮类似的法律挑战，结论是起诉该药物的医生和反堕胎团体没有法律地位。
根据，药物流产占2023年流产的近三分之二古特马赫研究所，一个专注于性健康和生殖健康的研究团体。这种口服药物通常与另一种药物米索前列醇联合使用，以诱导流产或帮助控制早期流产，最长可达10周。
Supreme Court temporarily extends access to abortion pill mifepristone by mail
Supreme Court Justice Samuel Alito has temporarily extended an order that maintains nationwide access to the abortion pill mifepristone by mail and through telehealth visits.
The administrative stay due to expire Monday will now stay in place until Thursday at 5 p.m. ET. Alito didn't elaborate on the decision.
The Supreme Court is considering an emergency application by pharmaceutical companies that produce mifepristone to lift a lower court's ruling barring the drug from being dispensed by telehealth providers or distributed by mail as litigation continues.
The state of Louisiana, which bans abortion at all stages of pregnancy with limited exceptions, originally brought the case in a bid to block mail-order access to the abortion pill, alleging federal regulators did not properly consider safety risks when discontinuing an in-person doctor visit requirement.
Drug makers, public health organizations and abortion rights advocates insist legally mandated reviews were conducted and that the drug has a lower adverse effects rate than penicillin and Viagra.
Mifepristone became a target for lawsuits after the Supreme Court overturned Roe v. Wade in 2022. In 2024, the justicesunanimously rejecteda similar legal challenge to mifepristone, concluding that the doctors and anti-abortion groups who sued over the drug did not have standing.
Medication abortion accounted for nearly two-thirds of abortions in 2023, according to theGuttmacher Institute, a research group focusing on sexual and reproductive health. The oral drug is typically used in combination with another drug, misoprostol, to induce an abortion or to help manage an early miscarriage, up to 10 weeks' gestation.
